Roche to Buy Bowel-Disease Drug From Roivant, Pfizer for More Than $7 Billion
Updated Oct. 23, 2023 6:55 am ETRoche Holding has agreed to buy the developer of a bowel-disease treatment from Roivant ...
© CFO News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.